(DHC) Diversified Healthcare Trust - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US25525P1075

Senior Living, Medical Office, Life Science

Stock: Health Care REITs
Age 25.9y
MCap 1,332m
Avg Vol 1.08M (5.62M USD)
Beta 0.755
Volatility 38.68%

EPS (Earnings per Share)

EPS (Earnings per Share) of DHC over the last years for every Quarter: "2020-12": -0.07, "2021-03": -0.28, "2021-06": -0.14, "2021-09": -0.38, "2021-12": -0.4, "2022-03": -0.37, "2022-06": -0.46, "2022-09": -0.34, "2022-12": -0.27, "2023-03": -0.22, "2023-06": -0.3, "2023-09": -0.28, "2023-12": -0.43, "2024-03": -0.36, "2024-06": -0.35, "2024-09": -0.4118, "2024-12": -0.271, "2025-03": -0.0374, "2025-06": -0.38, "2025-09": -0.38, "2025-12": 0,
EPS CAGR: 44.45%
EPS Trend: 39.5%
Last SUE: 1.28
Qual. Beats: 1

Revenue

Revenue of DHC over the last years for every Quarter: 2020-12: 384.909, 2021-03: 362.724, 2021-06: 346.341, 2021-09: 337.416, 2021-12: 336.731, 2022-03: 310.733, 2022-06: 313.028, 2022-09: 322.92, 2022-12: 336.885, 2023-03: 346.03, 2023-06: 346.219, 2023-09: 356.524, 2023-12: 361.535, 2024-03: 370.776, 2024-06: 371.392, 2024-09: 373.64, 2024-12: 379.619, 2025-03: 386.864, 2025-06: 382.712, 2025-09: 388.706, 2025-12: null,
Rev. CAGR: 3.90%
Rev. Trend: 94.1%
Last SUE: 1.44
Qual. Beats: 1

Dividends

Dividend Yield 1.38%
Yield on Cost 5y 0.99%
Yield CAGR 5y 0.00%
Payout Consistency 88.7%
Payout Ratio 2.3%
Risk via 5d forecast
Volatility 38.7%
Value at Risk 5%th 57.9%
Relative Tail Risk -9.00%
Reward TTM
Sharpe Ratio 2.12
Alpha 174.08
CAGR/Max DD 1.82
Character TTM
Hurst Exponent 0.395
Beta 0.755
Beta Downside 0.871
Drawdowns 3y
Max DD 55.64%
Mean DD 23.24%
Median DD 21.78%

Description: DHC Diversified Healthcare Trust December 01, 2025

Diversified Healthcare Trust (NASDAQ:DHC) is a U.S. REIT that owns and operates a $6.7 billion portfolio of senior-living, medical-office, and life-science properties across 34 states and Washington, D.C. The trust’s 335 assets house over 26,000 senior-living units and roughly 6.9 million sq ft of clinical space, serving about 420 tenants. Management is provided by The RMR Group, a seasoned alternative-asset firm with ~$39 billion AUM and three decades of commercial-real-estate expertise.

Key operating metrics as of Q3 2025 show an occupancy rate near 96%, indicating strong demand in the aging-population-driven senior-housing segment. DHC’s funds-from-operations (FFO) grew ~5% year-over-year, outpacing the average 3% growth rate for Health Care REITs, while its weighted-average lease term remains above 7 years, providing cash-flow stability. The sector is highly sensitive to interest-rate movements and Medicare reimbursement policies, both of which can materially affect cap-rate compression and tenant credit quality.

For a deeper, data-driven look at DHC’s valuation dynamics, you might explore the analytical tools on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 0.5

Net Income (-352.1m TTM) > 0 and > 6% of Revenue (6% = 92.3m TTM)
FCFTA 0.00 (>2.0%) and ΔFCFTA -1.24pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 28.48% (prev 21.48%; Δ 7.00pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.00 (>3.0%) and CFO 18.7m > Net Income -352.1m (YES >=105%, WARN >=100%)
Net Debt (2.52b) to EBITDA (98.6m) ratio: 25.59 <= 3.0 (WARN <= 3.5)
Current Ratio 15.59 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (240.4m) change vs 12m ago 0.30% (target <= -2.0% for YES)
Gross Margin 17.57% (prev 16.87%; Δ 0.69pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 30.85% (prev 27.95%; Δ 2.90pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -1.06 (EBITDA TTM 98.6m / Interest Expense TTM 169.0m) >= 6 (WARN >= 3)

Altman Z'' -2.70

(A) 0.09 = (Total Current Assets 468.0m - Total Current Liabilities 30.0m) / Total Assets 4.68b
(B) -0.63 = Retained Earnings (Balance) -2.94b / Total Assets 4.68b
(C) -0.04 = EBIT TTM -179.0m / Avg Total Assets 4.98b
(D) -0.98 = Book Value of Equity -2.93b / Total Liabilities 3.00b
Total Rating: -2.70 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 43.99

1. Piotroski 0.50pt
2. FCF Yield 0.48%
3. FCF Margin 1.22%
4. Debt/Equity 1.61
5. Debt/Ebitda 25.59
6. ROIC - WACC (= -5.93)%
7. RoE -18.90%
8. Rev. Trend 94.06%
9. EPS Trend 39.48%

What is the price of DHC shares?

As of January 17, 2026, the stock is trading at USD 5.92 with a total of 4,907,178 shares traded.
Over the past week, the price has changed by +9.63%, over one month by +22.82%, over three months by +44.73% and over the past year by +188.71%.

Is DHC a buy, sell or hold?

Diversified Healthcare Trust has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold DHC.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 1
  • Sell: 1
  • Strong Sell: 0

What are the forecasts/targets for the DHC price?

Issuer Target Up/Down from current
Wallstreet Target Price 5.8 -2.9%
Analysts Target Price 5.8 -2.9%
ValueRay Target Price 6.4 7.6%

DHC Fundamental Data Overview January 17, 2026

P/S = 0.866
P/B = 0.7886
Revenue TTM = 1.54b USD
EBIT TTM = -179.0m USD
EBITDA TTM = 98.6m USD
Long Term Debt = 2.72b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.72b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.52b USD (from netDebt column, last quarter)
Enterprise Value = 3.85b USD (1.33b + Debt 2.72b - CCE 201.4m)
Interest Coverage Ratio = -1.06 (Ebit TTM -179.0m / Interest Expense TTM 169.0m)
EV/FCF = 206.2x (Enterprise Value 3.85b / FCF TTM 18.7m)
FCF Yield = 0.48% (FCF TTM 18.7m / Enterprise Value 3.85b)
FCF Margin = 1.22% (FCF TTM 18.7m / Revenue TTM 1.54b)
Net Margin = -22.90% (Net Income TTM -352.1m / Revenue TTM 1.54b)
Gross Margin = 17.57% ((Revenue TTM 1.54b - Cost of Revenue TTM 1.27b) / Revenue TTM)
Gross Margin QoQ = 16.29% (prev 18.33%)
Tobins Q-Ratio = 0.82 (Enterprise Value 3.85b / Total Assets 4.68b)
Interest Expense / Debt = 0.03% (Interest Expense 774.0k / Debt 2.72b)
Taxrate = 21.0% (US default 21%)
NOPAT = -141.4m (EBIT -179.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 15.59 (Total Current Assets 468.0m / Total Current Liabilities 30.0m)
Debt / Equity = 1.61 (Debt 2.72b / totalStockholderEquity, last quarter 1.69b)
Debt / EBITDA = 25.59 (Net Debt 2.52b / EBITDA 98.6m)
Debt / FCF = 135.0 (Net Debt 2.52b / FCF TTM 18.7m)
Total Stockholder Equity = 1.86b (last 4 quarters mean from totalStockholderEquity)
RoA = -7.06% (Net Income -352.1m / Total Assets 4.68b)
RoE = -18.90% (Net Income TTM -352.1m / Total Stockholder Equity 1.86b)
RoCE = -3.90% (EBIT -179.0m / Capital Employed (Equity 1.86b + L.T.Debt 2.72b))
RoIC = -3.05% (negative operating profit) (NOPAT -141.4m / Invested Capital 4.63b)
WACC = 2.88% (E(1.33b)/V(4.06b) * Re(8.71%) + D(2.72b)/V(4.06b) * Rd(0.03%) * (1-Tc(0.21)))
Discount Rate = 8.71% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.25%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈45.9m ; Y1≈30.2m ; Y5≈13.8m
Fair Price DCF = N/A (negative equity: EV 438.4m - Net Debt 2.52b = -2.08b; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 39.48 | EPS CAGR: 44.45% | SUE: 1.28 | # QB: 1
Revenue Correlation: 94.06 | Revenue CAGR: 3.90% | SUE: 1.44 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.15 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=-0.57 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+28.2% | Growth Revenue=+3.6%

Additional Sources for DHC Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle